Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Change in Inventory (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Change in Inventory for 4 consecutive years, with $18314.0 as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 715.77% to $18314.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25940.0 through Dec 2025, up 184.31% year-over-year, with the annual reading at $25940.0 for FY2025, 184.31% up from the prior year.
  • Change in Inventory for Q4 2025 was $18314.0 at bioAffinity Technologies, up from -$8737.0 in the prior quarter.
  • The five-year high for Change in Inventory was $20281.0 in Q2 2024, with the low at -$8997.0 in Q1 2024.
  • Average Change in Inventory over 4 years is $3346.8, with a median of $1151.5 recorded in 2022.
  • The sharpest move saw Change in Inventory skyrocketed 5000.57% in 2023, then tumbled 2182.38% in 2024.
  • Over 4 years, Change in Inventory stood at -$175.0 in 2022, then surged by 5000.57% to $8576.0 in 2023, then plummeted by 73.82% to $2245.0 in 2024, then skyrocketed by 715.77% to $18314.0 in 2025.
  • According to Business Quant data, Change in Inventory over the past three periods came in at $18314.0, -$8737.0, and $5189.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.